Fingerprint
Dive into the research topics of 'Impact of extended Elexacaftor/Tezacaftor/Ivacaftor therapy on the gut microbiome in cystic fibrosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Impact of extended Elexacaftor/Tezacaftor/Ivacaftor therapy on the gut microbiome in cystic fibrosis
Ryan Marsh, Claudio Dos Santos, Alexander Yule, Neele S Dellschaft, Caroline L Hoad, Christabella Ng, Giles Major, Alan R Smyth, Damian Rivett, Christopher van der Gast*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
4
Citations
(Scopus)
10
Downloads
(Pure)